Global Women's Health Market to Grow 3.84% - Rise in STIs - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Women's Health Market 2016-2020" report to their offering.

The global women's health market is set to grow at a CAGR of 3.84% during the period 2016-2020.

The limited funding for public health clinics globally has led to a rise in common STIs such as chlamydia, syphilis, and gonorrhea. Such diseases should be treated urgently as they can cause pelvic inflammatory diseases, stillbirths, neonatal infections, and infertility. Various public health institutes highly recommend that women who are sexually active must undergo STI screening once a year. The increase in detections of STIs will positively affect this market.

According to the report, the rise in the number of older women worldwide has spurred the market, with companies investing in R&D to develop new women's health solutions to enhance their existing portfolio. Many of the diseases women are diagnosed with are associated with old age. This will fuel the growth of the women's health market over the forecast period.

Further, the report states that one of the major issues faced by women is the cost of treatment and the inaccessibility of therapies to treat diseases, especially in developing and under-developing countries.

Companies Profiled:

  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals
  • Agile Therapeutics
  • Amgen
  • Apothecus Pharmaceutical
  • AstraZeneca
  • Blairex Laboratories
  • Bristol-Myers Squibb
  • EffRx
  • Ferring International Center
  • GlaxoSmithKline
  • HLL Lifecare
  • Janssen Pharmaceutical
  • Lipocine
  • Ligand Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mayer Laboratories
  • Medicines 360
  • Neurocrine Biosciences
  • Novartis
  • Novo Nordisk
  • Pantarhei Bioscience
  • Sanofi

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by application

PART 07: Geographical segmentation

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape

PART 14: Key vendor analysis

For more information visit http://www.researchandmarkets.com/research/b3jqp6/global_womens

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716